← GODS Home
Elk Velvet Antler
Ingredient · 9 compounds · 7 conditions

Elk Velvet Antler is profiled across the CytoSolve® knowledge base and mapped to the disease biology it influences — tracing each of its compounds through disease, biological process, molecular pathway and down to individual biomarkers, with source videos and references at each step.

Compare
Add ingredients to compare side-by-side

Comparison

All Compound Disease Biological Process Molecular Pathway
Compound · 5 disease(s) · 5 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NF-κB Signaling
◈ TargetNF-κB
IL-6 and TNF-α
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
LPS/TLR Signaling
◈ TargetTNF-α
TNF-α
Disease · 1 process(es) · 1 pathway(s)
Muscle Hypertrophy1 pathway
AKT/mTOR Signaling
◈ TargetP-AKT
PKC, Rac1
Disease · 1 process(es) · 1 pathway(s)
Sexual Dysfunction1 pathway
Ca2+ Signaling
◈ TargetCa2+ Influx
BCL-xS, BCL-xL
Disease · 1 process(es) · 1 pathway(s)
Osteoclastogenesis1 pathway
RANK/RANKL Signaling
◈ TargetOsteoprotegerin
Osteoprotegerin
Compound · 3 disease(s) · 3 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Apoptosis1 pathway
ROS/Caspase-3 Signaling
◈ TargetROS
BCL-2, BAX, Caspase-3
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
LPS/TLR Signaling
◈ TargetNF-κB
IL‐1β, NO
Disease · 1 process(es) · 1 pathway(s)
Oxidative Stress1 pathway
Nrf2/Keap1 Signaling
◈ TargetNrf2
ROS, HO-1, SOD, CAT
Compound · 4 disease(s) · 5 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Neurodegeneration1 pathway
Nrf2/HO/JNK Signaling
◈ TargetJNK
HO-1, BAX, IL-1β
Disease · 2 process(es) · 2 pathway(s)
Inflammation1 pathway
Arachidonic Acid Signaling
◈ TargetCOX-2
COX-2, TNF-α, PGE-2
Bone Degeneration1 pathway
NF-κB Signaling
◈ TargetNF-κB
iNOS, COX-2, IL-6, IL-β
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
RANKL/JNK Signaling
◈ TargetP-JNK
IL-6 and TNF-α
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NF-κB Signaling
◈ TargetNF-κB
iNOS, COX-2, TNF-α
Compound · 2 disease(s) · 2 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
TNF-α Signaling
◈ TargetNF-κB
IL-6, TNF-α
Disease · 1 process(es) · 1 pathway(s)
Muscle Hypertrophy1 pathway
mTOR Signaling
◈ TargetATP
S6K, 4EBP1
Compound · 2 disease(s) · 2 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Cartilage Degeneration1 pathway
TLR4/NF-κB Signaling
◈ TargetMMP-1
MMP-1
Disease · 1 process(es) · 1 pathway(s)
Sexual Dysfunction1 pathway
Ca2+ Signaling
◈ TargetCa2+ Influx
Ca2+ Level
Compound · 3 disease(s) · 3 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NLRP3 Signaling
◈ TargetNLRP3
MCP-1, iNOS, TNF-α, IL-6, COX-2
Disease · 1 process(es) · 1 pathway(s)
Hormonal Imbalance1 pathway
ERK Signaling
◈ TargetGPCR
Testosterone
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
LPS/TLR4 Signaling
◈ TargetMD2
IL-6, TNF-α
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
BDL/NF-κB Signaling
◈ TargetNF-κB
IL-10, IL-6, TNF-α
Compound · 1 disease(s) · 1 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Muscle Hypertrophy1 pathway
mTOR Signaling
◈ TargetmTOR
S6K, 4EBP2
Compound · 2 disease(s) · 2 pathway(s)
Disease · 1 process(es) · 1 pathway(s)
Osteoclastogenesis1 pathway
NF-κB Signaling
◈ TargetNF-κB
NFATc1, TRAP, MMP-9, CTSK
Disease · 1 process(es) · 1 pathway(s)
Inflammation1 pathway
NF-κB Signaling
◈ TargetPPARα
IL-1β, TNF-α, IL-6.